Tag: Field Trip Health - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

Post published:April 5, 2022
Post category:Press Release

Read more about the article Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

Post published:March 3, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

Post published:February 15, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

Post published:February 1, 2022
Post category:Press Release

Read more about the article Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Post published:January 11, 2022
Post category:Press Release

Read more about the article Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies

Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies

Post published:January 6, 2022
Post category:Press Release

Read more about the article Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality

Post published:December 14, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

Post published:November 15, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET

Post published:November 2, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton

Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton

Post published:October 19, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.